Evidence map›Paper›PMID 34258672›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2022

Language Proficiency and Survival in Pancreatic Cancer: a Propensity Score-Matched Analysis.

Rodrigo Calvillo-Ortiz, J Christopher Polanco-Santana, Manuel Castillo-Angeles, Benjamin G Allar, Luis Anguiano-Landa, Eiman Ghaffarpasand, Courtney Barrows, Mark P Callery, Tara S Kent

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rodrigo Calvillo-OrtizDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
J Christopher Polanco-SantanaDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
Manuel Castillo-AngelesDivision of Trauma, Burn, and Surgical Critical Care, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Benjamin G AllarDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
Luis Anguiano-LandaDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
Eiman GhaffarpasandDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
Courtney BarrowsDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
Mark P CalleryDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA.
Tara S KentDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 30 Brookline Avenue Palmer 6, Boston, MA, 02215, USA. tkent@bidmc.harvard.edu.ORCID 0000-0002-8648-9729
Beth Israel Deaconess Medical Center · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimited English proficiency has been shown to negatively affect health outcomes. However, as of now, little is known about survival rates of patients with limited English proficiency (LEP) and pancreatic ductal adenocarcinoma (PDAC) when compared to patients with English proficiency (EP) in an urban, non-safety net setting. We aimed to compare survival rates between patients with LEP and those with EP who had a diagnosis of PDAC.

methodsA single-institution retrospective propensity-matched cohort study of patients with biopsy-proven PDAC was undertaken. Demographics, clinical characteristics, and language information were collected for all participants. Patients were classified as having LEP or EP based on their preferred speaking language at the time of admission and matched on baseline characteristics using propensity scores. Survival analysis methods were used to study survival rates in patients with PDAC based on their EP status.

resultsOf 739 included patients, 71 (9.48%) had LEP, mean age was 68.4 ± 10.9, and 51.8% were female. Both groups of patients were comparable for age, gender, marital status, and time to treatment. LEP status was associated with higher odds of death in both unmatched (HR 1.65, 95% CI 1.22-2.22) and matched (HR 1.60, 95% CI 1.03-2.47) analyses. Additionally, patients with LEP had significantly decreased odds of receiving cancer-directed treatment and increased odds of advanced stage cancer at presentation.

conclusionsIn this cohort of patients with PDAC, LEP predicted worse survival. The results of this study suggest that, after accounting for interpreter use, other factors contribute to this disparity. Such factors, as yet unmeasured, may include health literacy and cultural expectations, for which further investigation is warranted to better understand and limit this survival disparity.

Indexed as

LanguagePancreatic NeoplasmsCohort StudiesCommunication BarriersFemaleHumansPropensity ScoreRetrospective StudiesCulturally competent careHealthcare disparitiesLimited English proficiencyPancreatic cancerPancreatic ductal carcinomaSurvival

Identifiers

PMID34258672
OpenAlexW3178602635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.